Cytori Cell Research Institute, Inc. (TYO:3750)

Japan flag Japan · Delayed Price · Currency is JPY
716.00
-12.00 (-1.65%)
Jun 13, 2025, 3:30 PM JST
-28.90%
Market Cap 6.39B
Revenue (ttm) 122.00M
Net Income (ttm) -2.14B
Shares Out 8.93M
EPS (ttm) -239.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,300
Average Volume 7,740
Open 728.00
Previous Close 728.00
Day's Range 710.00 - 729.00
52-Week Range 642.00 - 1,131.00
Beta 0.08
RSI 54.37
Earnings Date Aug 14, 2025

About TYO:3750

Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 16
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 3750
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.